News & Events about Indaptus Therapeutics Inc.
Dr. Newman also to give two presentations on the Companys Decoy platform at the event to be held in Boston May 9-11, 2023NEW YORK, May 01, 2023 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP, Indaptus or the Company), a biotechnology company focused on discovering and developing ...
Data presented were crucial to initiating its ongoing Phase 1 clinical trial with Decoy 20 in solid tumorsNEW YORK, April 19, 2023 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP, Indaptus or the Company), a biotechnology company focused on discovering and developing transformative ...
Globe Newswire
2 months ago
NEW YORK, March 22, 2023 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP), a biotechnology company focused on discovering and developing transformative therapeutics for patients, today announcesthat it will participate at the Investor Summit Conference being held virtually on March 29...
Globe Newswire
2 months ago
Enrollment Underway in Phase 1 Clinical Trial of Decoy20 for Treatment of Solid Tumors with First Patient Dosed In March 2023NEW YORK, March 17, 2023 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) (Indaptus or the Company), today announced financial results for the fourth quarter and...
Globe Newswire
2 months ago
NEW YORK, March 15, 2023 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP, Indaptus or the Company), a biotechnology company focused on discovering and developing transformative therapeutics for patients, today announces that the American Association for Cancer Research (AACR) has ...